iFlytek Medical has established a strategic partnership in AI-driven healthcare with PT DSST Mas Gemilang, a subsidiary of Indonesia’s Sinar Mas Group, representing a significant leap forward in its global expansion. Southeast Asia is witnessing a surge in demand for healthcare digitization; however, the region is grappling with challenges such as a scarcity of primary healthcare professionals and an uneven distribution of medical resources, thereby opening up tremendous opportunities for the AI healthcare sector. The collaboration adopts a “technology export + joint operation within the local ecosystem” approach. In this model, iFlytek Medical supplies comprehensive AI healthcare technologies, core intellectual property rights, and insights gleaned from national-level projects, while the partner brings to the table government and enterprise networks, digital infrastructure, and localized operational assistance. Together, they will drive the execution of high-value business scenarios, encompassing AI systems for end-to-end disease diagnosis and treatment, national-level epidemic surveillance platforms, intelligent medical imaging and remote radiology services, and digital hospital enhancements. These scenarios align seamlessly with iFlytek Medical’s current product lineup, enabling the reuse of capabilities and effective cost management. By capitalizing on the Indonesian market, the initiative is set to forge a second overseas growth trajectory, tapping into growth prospects through model replication and broadening the scope for long-term development.